See every side of every news story
Published loading...Updated

PCI Pharma Reportedly Valued at $10B with New PE Investments ...

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its geographic reach.

8 Articles

PHILADELFIA, 15 Jul 2025 (BSW) - PCI Pharma Services ("PCI" or "Company"), a world-leading global contract development and manufacturing organization (CDMO) focused on innovative biotherapy, announced today that it received a strategic investment co-directed by Bain Capital and the...

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

biopharmadive.com broke the news in on Monday, July 14, 2025.
Sources are mostly out of (0)

Similar News Topics